360 related articles for article (PubMed ID: 12645411)
1. [Vigabatrin and visual field defects. A Danish material with evaluation of different screening methods].
Riise P; Fledelius HC; Rogvi-Hansen Bà
Ugeskr Laeger; 2003 Mar; 165(10):1034-8. PubMed ID: 12645411
[TBL] [Abstract][Full Text] [Related]
2. Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal.
Newman WD; Tocher K; Acheson JF
Eye (Lond); 2002 Sep; 16(5):567-71. PubMed ID: 12194070
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic and asymptomatic visual loss in patients taking vigabatrin.
Daneshvar H; Racette L; Coupland SG; Kertes PJ; Guberman A; Zackon D
Ophthalmology; 1999 Sep; 106(9):1792-8. PubMed ID: 10485552
[TBL] [Abstract][Full Text] [Related]
4. [Visual field changes secondary to vigabatrin treatment].
Mauri-Llerda JA; Iñiguez C; Tejero-Juste C; Santos-Lasaosa S; Escalza-Cortina I; Ascaso-Puyuelo J; Abad-Alegría F; Morales-Asín F
Rev Neurol; 2000 Dec 16-31; 31(12):1104-8. PubMed ID: 11205539
[TBL] [Abstract][Full Text] [Related]
5. [Study of visual field and vigabatrin treatment in children].
Pelosse B; Momtchilova M; Roubergue A; Doummar D; Billette de Villemeur T; Laroche L
J Fr Ophtalmol; 2001 Dec; 24(10):1075-80. PubMed ID: 11913238
[TBL] [Abstract][Full Text] [Related]
6. The natural history of Vigabatrin associated visual field defects in patients electing to continue their medication.
Best JL; Acheson JF
Eye (Lond); 2005 Jan; 19(1):41-4. PubMed ID: 15094729
[TBL] [Abstract][Full Text] [Related]
7. Is visual field constriction in epilepsy patients treated with vigabatrin reversible?
Schmidt T; Rüther K; Jokiel B; Pfeiffer S; Tiel-Wilck K; Schmitz B
J Neurol; 2002 Aug; 249(8):1066-71. PubMed ID: 12195456
[TBL] [Abstract][Full Text] [Related]
8. Vigabatrin-associated visual field defects in children.
Russell-Eggitt IM; Mackey DA; Taylor DS; Timms C; Walker JW
Eye (Lond); 2000 Jun; 14 ( Pt 3A)():334-9. PubMed ID: 11026995
[TBL] [Abstract][Full Text] [Related]
9. [Visual field disturbances in epileptic patients treated with vigabatrin (sevril)].
Gross-Tsur V; Lahat E; Banin E; Shahar E; Shalev R
Harefuah; 2002 Mar; 141(3):247-9, 315. PubMed ID: 11944216
[TBL] [Abstract][Full Text] [Related]
10. Vigabatrin-associated visual field constriction in a longitudinal series. Reversibility suggested after drug withdrawal.
Fledelius HC
Acta Ophthalmol Scand; 2003 Feb; 81(1):41-6. PubMed ID: 12631018
[TBL] [Abstract][Full Text] [Related]
11. Visual field constriction is not limited to children treated with vigabatrin.
Wohlrab G; Boltshauser E; Schmitt B; Schriever S; Landau K
Neuropediatrics; 1999 Jun; 30(3):130-2. PubMed ID: 10480207
[TBL] [Abstract][Full Text] [Related]
12. Comparison between semiautomated kinetic perimetry and conventional Goldmann manual kinetic perimetry in advanced visual field loss.
Nowomiejska K; Vonthein R; Paetzold J; Zagorski Z; Kardon R; Schiefer U
Ophthalmology; 2005 Aug; 112(8):1343-54. PubMed ID: 15996734
[TBL] [Abstract][Full Text] [Related]
13. Visual impairment in children with epilepsy treated with vigabatrin.
Gross-Tsur V; Banin E; Shahar E; Shalev RS; Lahat E
Ann Neurol; 2000 Jul; 48(1):60-4. PubMed ID: 10894216
[TBL] [Abstract][Full Text] [Related]
14. Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study.
Schmitz B; Schmidt T; Jokiel B; Pfeiffer S; Tiel-Wilck K; Rüther K
J Neurol; 2002 Apr; 249(4):469-75. PubMed ID: 11967655
[TBL] [Abstract][Full Text] [Related]
15. Vigabatrin-associated loss of vision: rarebit perimetry illuminates the dose-damage relationship.
Frisén L
Acta Ophthalmol Scand; 2004 Feb; 82(1):54-8. PubMed ID: 14738486
[TBL] [Abstract][Full Text] [Related]
16. Visual field assessment in glaucoma: comparative evaluation of manual kinetic Goldmann perimetry and automated static perimetry.
Agarwal HC; Gulati V; Sihota R
Indian J Ophthalmol; 2000 Dec; 48(4):301-6. PubMed ID: 11340889
[TBL] [Abstract][Full Text] [Related]
17. [Changes in visual field of a child treatment with vigabatrin for 2 years].
Mrugacz M; Bakunowicz-Łazarczyk A
Klin Oczna; 2003; 105(5):313-4. PubMed ID: 14746187
[TBL] [Abstract][Full Text] [Related]
18. [Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
Mrugacz M; Bakunowicz-Łazarczyk A
Klin Oczna; 2003; 105(5):326-8. PubMed ID: 14746191
[TBL] [Abstract][Full Text] [Related]
19. Inapparent visual field defects in multiple sclerosis patients.
Vidović T; Cerovski B; Vidović DH; Cerovski J; Novak-Laus K
Coll Antropol; 2005; 29 Suppl 1():67-73. PubMed ID: 16193681
[TBL] [Abstract][Full Text] [Related]
20. Visual field constriction on vigabatrin.
Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
